Carolina Neurosurgery and Spine Associates, Charlotte, NC 28207, USA.
J Neurosurg Spine. 2013 Jan;18(1):36-42. doi: 10.3171/2012.9.SPINE12555. Epub 2012 Nov 9.
The purpose of this study was to evaluate the long-term results of cervical total disc replacement (TDR) and anterior cervical discectomy and fusion (ACDF) in the treatment of single-level cervical radiculopathy.
The results of 2 separate prospective, randomized, US FDA Investigational Device Exemption pivotal trials (Bryan Disc and Kineflex|C) from a single investigational site were combined to evaluate outcomes at long-term follow-up. The primary clinical outcome measures included the Neck Disability Index (NDI), visual analog scale (VAS), and neurological examination. Patients were randomized to receive cervical TDR in 2 separate prospective, randomized studies using the Bryan Disc or Kineflex|C cervical artificial disc compared with ACDF using structural allograft and an anterior plate. Patients were evaluated preoperatively; at 6 weeks; at 3, 6, and 12 months; and then yearly for a minimum of 48 months. Plain radiographs were obtained at each study visit.
A total of 74 patients were enrolled and randomly assigned to either the cervical TDR (n = 41) or ACDF (n = 33) group. A total of 63 patients (86%) completed a minimum of 4 years follow-up. Average follow-up was 6 years (72 months) with a range from 48 to 108 months. In both the cervical TDR and ACDF groups, mean NDI scores improved significantly by 6 weeks after surgery and remained significantly improved throughout the minimum 48-month follow-up (p < 0.001). Similarly, the median VAS pain scores improved significantly by 6 weeks and remained significantly improved throughout the minimum 48-month follow-up (p < 0.001). There were no significant differences between groups in mean NDI or median VAS scores. The range of motion (ROM) in the cervical TDR group remained significantly greater than the preoperative mean, whereas the ROM in the ACDF group was significantly reduced from the preoperative mean. There was significantly greater ROM in the cervical TDR group compared with the ACDF group. There were 3 reoperations (7.3%) at index or adjacent levels in the cervical TDR group; all were cervical laminoforaminotomies. There were 2 adjacent-level reoperations in the cervical TDR group (4.9%). There was 1 reoperation (3.0%) in the ACDF group at an index or adjacent level (a second ACDF at the adjacent level). There was no statistically significant difference in overall reoperation rate or adjacent-level reoperation rate between groups.
Both cervical TDR and ACDF groups showed excellent clinical outcomes that were maintained over long-term follow-up. Both groups showed low index-level and adjacent-level reoperation rates. Both cervical TDR and ACDF appear to be viable options for the treatment of single-level cervical radiculopathy.
本研究旨在评估颈椎间盘置换术(TDR)和前路颈椎间盘切除融合术(ACDF)治疗单节段颈椎病的长期疗效。
将来自单一研究地点的 2 项独立的前瞻性、随机、美国 FDA 调查器械豁免关键试验(Bryan Disc 和 Kineflex|C)的结果合并,以评估长期随访时的结果。主要的临床疗效指标包括颈椎残障指数(NDI)、视觉模拟评分(VAS)和神经检查。患者被随机分为两组,分别接受 Bryan Disc 或 Kineflex|C 颈椎人工椎间盘与结构性同种异体移植物和前路板的 ACDF 治疗。患者在术前、术后 6 周、3、6 和 12 个月以及至少 48 个月进行评估。每次研究就诊时均拍摄平片。
共有 74 例患者入组并被随机分配至颈椎 TDR 组(n=41)或 ACDF 组(n=33)。共有 63 例患者(86%)完成了至少 4 年的随访。平均随访时间为 6 年(72 个月),随访时间为 48-108 个月。在颈椎 TDR 和 ACDF 两组中,术后 6 周 NDI 评分均显著改善,在整个至少 48 个月的随访中均保持显著改善(p<0.001)。同样,VAS 疼痛评分中位数在 6 周时显著改善,并在整个至少 48 个月的随访中保持显著改善(p<0.001)。两组间的平均 NDI 或 VAS 评分无显著差异。颈椎 TDR 组的活动度(ROM)明显大于术前平均值,而 ACDF 组的 ROM 明显低于术前平均值。颈椎 TDR 组的 ROM 明显大于 ACDF 组。颈椎 TDR 组有 3 例(7.3%)索引或相邻水平再手术,均为颈椎椎板成形术。颈椎 TDR 组有 2 例(4.9%)相邻水平再手术。ACDF 组有 1 例(3.0%)索引或相邻水平再手术(相邻水平的第二次 ACDF)。两组总体再手术率或相邻水平再手术率无统计学差异。
颈椎 TDR 和 ACDF 两组均显示出优异的临床疗效,且在长期随访中得以维持。两组索引水平和相邻水平的再手术率均较低。颈椎 TDR 和 ACDF 似乎都是治疗单节段颈椎病的可行选择。